Diquas LX Eye Drops contain diquafosol sodium, a P2Y₂ receptor agonist that acts directly on conjunctival tissue to improve tear production and ocular surface health.
The active ingredient stimulates the secretion of water and secretory mucin, promotes the production of membrane-bound mucin in the corneal epithelium, and increases the lipid content of tears. Through these combined actions, Diquas LX helps correct tear film abnormalities both quantitatively and qualitatively, restoring the ocular surface closer to its normal condition.
As a result, these eye drops effectively relieve symptoms of dry eye syndrome and support healing in corneal epithelial disorders, while offering a reduced dosing frequency compared to some conventional treatments.
Key Characteristics
Active Ingredient: Diquafosol sodium
Concentration: 3%
Indication: Treatment of dry eye syndrome (keratoconjunctival epithelial damage)
Mechanism of Action:
Stimulates secretion of tear fluid and mucin
Enhances lipid content in the tear film
Improves tear film stability and ocular surface integrity
Patient Benefit: Lower frequency of use may reduce treatment burden